Ethics in the Pharma Business – Why Did Ely Lilly Prescribe Non-Working Drugs?
You might have heard of this already – Ely Lilly has been actively marketing drugs supposed to counteract the Alzheimer disease for older people, which did not work. And this is more than a $6.8 billion suit already – the prosecutors have lots of documents to prove it, according to the media.
Insurers and other so-called third-party payers evaluated that Lilly could pay as much as $6.8 billion in damages for downplaying Zyprexa’s health risks, including excessive weight gain and the risk of contracting diabetes, and marketing the drug for unapproved uses to pump up profits, says Bloomberg.Read More »Ethics in the Pharma Business – Why Did Ely Lilly Prescribe Non-Working Drugs?